13 Jun Additional Risk Minimisation Measures (aRMM)
There has been a change in receipt of aRMM at the Icelandic Medicines Agency (IMA).
From 1 June 2017 IMA will take seven days to ensure that all relevant documents are enclosed in an application for aRMM evaluation. This is done to facilitate IMA’s review of the material that has been submitted.
Link to information is here:
For more information, please contact our IS member: http://www.dayzero.is/